Skip to main content
OpenTrials
Completed

NCT Number: NCT00873249

Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia

This study is a 6-month, multicenter, randomized study to assess the effect of daily SMS reminders sent during 3 months in the adherence to oral antipsychotic treatment in stabilized outpatients with schizophrenia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Alicante, Spain

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female patients older than 18 years
  • With a diagnosis of schizophrenia (DSM-IV TR criteria)
  • Stabilized out-patients
  • Under oral antipsychotic monotherapy

Exclusion criteria

  • Administration of a depot antipsychotic drug
  • Suicide risk

Treatment and study plan

Primary outcomes

  1. Morisky Green Questionnaire

    Time frame: baseline, at months 3 and 6

Secondary outcomes

  1. Clinical Global Impression- Schizophrenia (CGI-SCH)

    Time frame: baseline, at months 3 and 6

  2. Register of Adherence to Treatment (RAT)

    Time frame: baseline, at months 3 and 6

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Effect of Daily SMS Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia

Acronym: SMS

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Apr 1, 2009
Registry last updated
Mar 24, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.